miR-301b also targets PIK3CB (P110-β), the catalytic subunit of PI3Kβ, which has been shown to enhance cell proliferation and promote tumorigenesis in breast cancer (Figure 5A), reviewed in (61). This evidence concerns the gene PIK3CB and breast carcinoma.